Genfit
GNFT | NASDAQ
$8.95
+$0.35 (+4.07%)
At close: Nov 10, 2025, 3:55 PM ET
+4.07%
(1D)Rating
Key Statistics
Market Data
Market Cap $445.68M
1D Range
8.85 9.00
52W Range
2.55 10.00
Valuation (TTM)
PE -10.52
PB 7.21
EV/EBITDA -17.61
Valuation (NTM)
Forward PE N/A
Forward PEG 1.09
Price Target $13.00
Cash Flow
FCF Yield -1.1%
SBC Adj. FCF Yield -1.3%
SBC Impact -11.6%
Margins
Gross Margin 99.5%
Operating Margin -67.3%
FCF Margin -10.8%
Growth (CAGR)
Revenue 3Y | 5Y 74.5% |
50.0%
Dil EPS 3Y | 5Y 16.1% |
26.5%
FCF 3Y | 5Y 83.2% |
18.5%
Returns
ROA 1.0%
ROE 2.2%
ROIC 2.0%
Financial Health
Net Debt
€26.75M ($31.53M)
Current Ratio 1.23
Interest Coverage 0.69
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Genfit S.A. operates as a biopharmaceutical company dedicated to discovering and advancing novel therapeutic candidates and diagnostic solutions for a range of metabolic and liver-related diseases. It...
Sector Healthcare
Industry Biotechnology
Employees 180
IPO Date Mar 27, 2019
Website www.genfit.com
Fiscal Year January - December
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove GNFT